Induration – 2.0% of participants
Itching – 1.0% of participants
Expected Clinical Benefits
Complications as a result of diabetes mellitus (including, but not limited to:
diabetic retinopathy, diabetic nephropathy) are well documented.
1
Self-monitoring
of blood glucose (SMBG) by patients has revolutionised management of diabetes.
2
Using glucose monitoring devices patients with diabetes can work to achieve and
maintain specific glycaemia goals. Given the results of the Diabetes Control and
Complications Trial (DCCT)
3
and other studies, there is broad consensus on the
health benefits of normal or near-normal blood glucose levels and on the
importance, especially in insulin-treated patients, of glucose monitoring devices in
treatment e"orts designed to achieve these glycaemic goals. Based principally on
the DCCT results, experts recommend that most individuals with diabetes should
attempt to achieve and maintain blood glucose levels as close to normal as is
safely possible. Most patients with diabetes, especially insulin treated patients, can
achieve this goal only by using glucose monitoring devices.
References
1. Textbook of Diabetes, Volumes 1 & 2; Pickup and Williams, 1999.
2. ADA Position Statement. Test of glycaemia in diabetes. Diabetes Care 2003;
26(Suppl.1) S106-108.
3. Diabetes Control and Complications Trial Research Group (DCCT): The e"ect of
intensive treatment of diabetes on the development and progression of long term
complications in insulin dependent diabetes mellitus. New Engl J Med, 329: 977-86;
1993.
Customer Service:
www.FreeStyleLibre.com
Patent:
www.Abbott.com/patents
FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks
To Next Page
Loading...
Need help?
General
